Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer
S.M. Jamshedur Rahman, … , Jamey D. Young, Pierre P. Massion
S.M. Jamshedur Rahman, … , Jamey D. Young, Pierre P. Massion
Published November 17, 2016
Citation Information: JCI Insight. 2016;1(19):e88814. https://doi.org/10.1172/jci.insight.88814.
View: Text | PDF
Research Article Metabolism Oncology

The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer

  • Text
  • PDF
Abstract

The molecular determinants of lung cancer risk remain largely unknown. Airway epithelial cells are prone to assault by risk factors and are considered to be the primary cell type involved in the field of cancerization. To investigate risk-associated changes in the bronchial epithelium proteome that may offer new insights into the molecular pathogenesis of lung cancer, proteins were identified in the airway epithelial cells of bronchial brushing specimens from risk-stratified individuals by shotgun proteomics. Differential expression of selected proteins was validated by parallel reaction monitoring mass spectrometry in an independent set of individual bronchial brushings. We identified 2,869 proteins, of which 312 proteins demonstrated a trend in expression. Pathway analysis revealed enrichment of carbohydrate metabolic enzymes in high-risk individuals. Glucose consumption and lactate production were increased in human bronchial epithelial BEAS2B cells treated with cigarette smoke condensate for 7 months. Increased lipid biosynthetic capacity and net reductive carboxylation were revealed by metabolic flux analyses of [U-13C5] glutamine in this in vitro model, suggesting profound metabolic reprogramming in the airway epithelium of high-risk individuals. These results provide a rationale for the development of potentially new chemopreventive strategies and selection of patients for surveillance programs.

Authors

S.M. Jamshedur Rahman, Xiangming Ji, Lisa J. Zimmerman, Ming Li, Bradford K. Harris, Megan D. Hoeksema, Irina A. Trenary, Yong Zou, Jun Qian, Robbert J.C. Slebos, Jennifer Beane, Avrum Spira, Yu Shyr, Rosana Eisenberg, Daniel C. Liebler, Jamey D. Young, Pierre P. Massion

×

Figure 4

Chronic exposure of the human bronchial epithelial BEAS2B cell line to increasing concentrations (20–120 μg/ml) of CSC for 7 months in vitro induces metabolic reprogramming.

Options: View larger image (or click on image) Download as PowerPoint
Chronic exposure of the human bronchial epithelial BEAS2B cell line to i...
(A) Overexpression of carbohydrate metabolic enzymes by Western blotting. (B) Lactate production and (C) glucose consumption were measured by the YSI 2300 STAT Plus Analyzer. (D) Fractional acetyl-CoA enrichment and (E) the fraction of newly synthesized palmitate were determined by isotopomer spectral analysis of palmitate after 24 hours of labeling with [U-13C5] glutamine. The complete isotopolog distribution of palmitate is provided in the Supplemental Materials. (F) NADPH/NADP+ ratio measured by the NADP/NADPH-Glo assay kit (Promega). The results are represented as the mean ± SEM. CSC, cigarette smoke condensate. *P < 0.05, Student’s t test.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts